Published Date: 24 Apr 2023
Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.
Read Full NewsIn a survey, pediatric rheumatologists cite a lack of training, lack of data, turnaround time, and lab timing as barriers to broader use.
Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?
The mistaken belief that stress can cause cancer leads many affected individuals to blame themselves for their cancer.
Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving hemoglobin at delivery and achieving better anemia resolution.
Platelet-rich plasma injections into the anterior vaginal wall enhance sexual function in premenopausal women.
The FDA said on Friday it has notified manufacturers of certain Parkinson's disease treatments to update their prescribing information with a...
In a nine-wave online survey of 418 adults over 18 months, researchers find fatigue levels do not fluctuate seasonally — only everyday activity fatigue falls as days lengthen.
1.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
2.
Radioactive ion beams successfully treat animal tumors in study
3.
Early breast cancer detection may be possible with a wearable ultrasound scanner.
4.
high response rate when using a bispecific antibody to treat R/R multiple myeloma.
5.
Many patients learn they could have cancer in the emergency department
1.
What You Need To Know About Secondary Polycythemia: Treatment & Symptoms
2.
Discovering the Benefits of TNK: A Comprehensive Blog Article
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Unveiling the Invisible: The Transformative Role of Radiomics in Precision Oncology
5.
Unlocking the Potential of Palbociclib: A Comprehensive Overview
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation